News & Events

Filter Year   Keywords   > Submit

Page 2 3

Celladon Corporation Announces Publication of Data

27 / 10 / 2014

New Gene Therapy Approach Shown To Reverse Heart Damage and Improve Long Term Cardiac Function Following Myocardial Infarction in Animal Models.

> Read More

Ivantis Announces HYDRUS II Glaucoma Study Met Primary Endpoint In a Randomized Controlled Trial

24 / 10 / 2014

Results from Landmark International Study Show Hydrus™ Microstent Significantly Reduced Intraocular Pressure and Medication Use in Patients with Glaucoma Undergoing Cataract Surgery

> Read More

Updated Clinical Data from Numerous Studies of AirXpanders' AeroForm

14 / 10 / 2014

Clinical data consistently show that patients undergoing breast reconstruction after a mastectomy can complete expansion significantly faster with AeroForm™ expanders than traditional saline expanders Separate analyses show that it is safe to fly with AeroForm implanted and patients can undergo radiation therapy for residual breast cancer while completing the expansion process

> Read More

Neurovance Appoints Brigitte Robertson, MD, Vice President, Clinical Development

05 / 08 / 2014

Dr. Robertson Brings ADHD Expertise to Advance Neurovance’s Centanafadine SR Program Neurovance’s Lead Product EB-1020 SR Granted Non-Proprietary Name; Now Called Centanafadine SR

> Read More

Celladon Corporation Announces In-License of Stem Cell Factor Development Program

21 / 07 / 2014

License Brings Novel Gene Therapy Approach for in situ Targeting of Multi-Potent Stem Cells for the Heart

> Read More

Displaying records 1-25 of 53